Last $104.76 USD
Change Today +3.77 / 3.73%
Volume 14.9M
GILD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Xetra
As of 8:10 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John C. Martin Ph.D.

Chairman and Chief Executive Officer, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 170 board members in 4 different organizations across 4 different industries.

See Board Relationships
62$15,451,862
As of Fiscal Year 2013

Background*

Dr. John C. Martin, Ph.D. is the Chief Executive Officer of Gilead Sciences Inc. since April 1996 and served as its President from April 1996 to May 2008. Dr. Martin joined Gilead Sciences Inc. in October 1990 as Vice President for Research and Development. He had been with Syntex Corporation from 1978 to 1984. He served as the President of the International Society for Antiviral Research. He has been Chairman of the Board of Gilead Sciences Inc., since May 2008. He ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

Director
1996-Present
Chairman and Chief Executive Officer
2007-2012
Former Director and Member of Compensation Committee
2009-Present
Director

Education*

PhD
The University of Chicago
MBA
Golden Gate University

Other Affiliations*

Annual Compensation*

Salary$1,568,765
Total Annual Compensation$1,568,765

Stock Options*

Restricted Stock Awards$5,081,801
All Other Compensation$7,500
Exercised Options3,386,904
Exercised Options Value$158,876,322
Exercisable Options7,495,383
Exercisable Options Value$441,505,554
Unexercisable Options1,222,875
Unexercisable Options Value$57,242,983
Total Value of Options$657,624,858
Total Number of Options12,105,162

Total Compensation*

Total Annual Cash Compensation$5,120,015
Total Short Term Compensation$1,568,765
Other Long Term Compensation$5,089,301
Total Calculated Compensation$15,451,862
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $104.76 USD +3.77

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.